跳至主要内容
临床试验/ITMCTR2000003825
ITMCTR2000003825尚未招募未知

The TCM syndrome differentiation system of rheumatic immune-related lung interstitial diseases was preliminarily established

Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • 1. Meet the diagnostic criteria of western medicine for this disease;
  • 2. Meet the diagnostic criteria of TCM syndrome differentiation and classification of this disease;
  • 3. Patients willing to actively cooperate with relevant examinations during the study;
  • 4. Patients were enrolled under the condition of informed consent and signed informed consent;
  • 5. For patients with pulmonary imaging manifestations that are typical but not clearly diagnosed and suspected to be rheumatic immune diseases mentioned above, 11 immunizations, ANA, ENA, dsDNA, ACL, ANCA, complement, and esR should be examined. Patients with rheumatic immunology disease may be clinically diagnosed by an experienced rheumatologist before they are included in the study.

排除标准

  • 1. Patients with other pulmonary diseases, such as bronchitis, chronic obstructive pulmonary disease, bronchiectasis, pleurisy, pulmonary hypertension, pulmonary tuberculosis, lung tumor, etc.;
  • 2. Patients with other organs such as cardiovascular, liver, kidney, hematopoietic system and other serious primary diseases and psychosis;
  • 3. Patients who do not agree to participate in this study.

研究者

发起方
Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine

相似试验